characteristics Total n=194 HIV n=129 HIV/HCV n=65 P <
Age years ± SD 48.3 ± 8.5 48.5 ± 9.4 47.7 ± 5.9  ns
Male/Female 121/73 74/55 47/18  ns
BMI (Kg/m2)± SD 23.5 ± 3.1 23.8 ± 3.4 22.8 ±2.7  ns
Fracture (n, %) 15 (7.7) 7 (5.4) 8 (12.3)  ns
Ethnicity (n, %):      Caucasian   181 (93.3)   119 (92.2)   62 (95.3)   ns
African 13   (6.7) 10 (7.7) 3 (4.6) ns
Smoking status (n, %):Non-smokers   62 (32.0)   50 (38.7)    12 (18.4) 0.03
Smokers 97 (50.0) 57 (44.2) 40 (61.5)
Former smokers 35 (28 %) 22 (17) 13 (20)    
Alcohol (n, %) 20 (10.3) 6 (4.6) 14 (21.5) 0.001
Drug addiction (n, %) 56 (28.8) 14 (10.8) 42 (64.6) 0.0001
IFG/Diabetes (n, %) 45 (23.2) 28 (21.7) 17 (26.1) ns
Time since HIV diagnosis (years) (range) 15 (0.1-29) 12 (0.1-28) 18 (0.1-29) 0.0001
Treatment-naïve (n, %) 9 (4.7) 7 (5.4) 2 (3.0) ns
Previous antiretroviral therapy (years) (range) 9 (0.5-26) 8 (0.5-23) 13 (0.5-26) 0.0001
Genotype 1/others (n, %) - - 40 (61) -
HIV: Human Immunodeficiency Virus; HCV: Hepatitis C Virus; SD: Standard Deviation; BMI: Body Mass Index; IFG: Impaired Fasting Glucose; FRS: Framingham Risk Score; ns: Not Significant.
Table 1: Baseline demographic, lifestyle and clinical characteristics of the194 study patients.
Goto home»